The challenge of comorbidity in clinical trials for multiple sclerosis

Conclusion: Our recommendations will help address knowledge gaps regarding comorbidity that interfere with the ability to interpret safety in monitored trials and will enhance the generalizability of findings from clinical trials to "real world" settings where the MS population commonly has comorbid conditions.

http://www.neurology.org/cgi/content/short/86/15/1437?rss=1

Source: Neurology - April 10, 2016 Category: Neurology Authors: Marrie, R. A., Miller, A., Sormani, M. P., Thompson, A., Waubant, E., Trojano, M., O'Connor, P., Reingold, S., Cohen, J. A., For the attendees of the International Workshop on Comorbidity in Multiple Sclerosis Tags: All Medical/Systemic disease, Clinical trials Methodology/study design, Multiple sclerosis VIEWS & amp;amp; REVIEWS Source Type: research